Clinical Trials · NCT06475586

Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus

CompletedPhase 4Semaglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Banja Luka
Enrollment
30
Start date
May 2023
Locations
1 site, Bosnia and Herzegovina
Primary endpoint
clinical characteristics of patients with psoriasis
View Semaglutide compound reference